期刊文献+

缬沙坦联合氨氯地平对老年性高血压左心室构型的影响 被引量:4

下载PDF
导出
摘要 目的探讨缬沙坦联合氨氯地平对老年性高血压左心室肥厚及构型的影响。方法将70例高血压患者随机分成两组,Ⅰ组(n=38)予以缬沙坦联合氨氯地平,Ⅱ组(n=32)单用氨氯地平,两组均给药6个月后,应用超声心动图测定治疗前后左心室构型的变化。结果缬沙坦联合氨氯地平组对高血压左心室构型的逆转效果明显优于氨氯地平组(P<0.05)。结论缬沙坦联合氨氯地平在逆转高血压左室肥厚方面有良好作用,左室构型中向心性重构是防止心肌损害加重的关键阶段。
出处 《心脑血管病防治》 2005年第6期32-34,共3页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
  • 相关文献

参考文献10

二级参考文献4

共引文献87

同被引文献40

  • 1侯淑彦,杨朝宽,高恩民,王丽霞.3种剂量血管紧张素转换酶抑制剂对心肌肥厚逆转及对血管紧张素Ⅱ浓度的影响[J].中国实用内科杂志,1996,16(2):93-94. 被引量:9
  • 2Torikin A, Wing L. Management of isolated systolic hypertension. Prugs, 1996,51 (5) :738-749. 被引量:1
  • 3Loop T, Priebe HJ. Arterial hypertension: its impact on perioperative morbiditgy and mortalitgy Anasthesiol intensivemed schmerzther, 1998,33 (5) :292-299. 被引量:1
  • 4Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials[J]. Lancet, 2000, 355 (9207) :865 - 872. 被引量:1
  • 5Waeber B, Ruilope LM. Amlodipine and valsartan as components of a rational and effective fixed-dose combination [J].Vasc Health Risk Manag. 2009, 5 (1) : 165-174. 被引量:1
  • 6Krzesinski JM, Scheen AJ. A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan) : Exforge [J]. Rev Meal Liege, 2007,62 (11 ) : 688-694. 被引量:1
  • 7Mochizuki S, Shimizu M, Tainguchi I, et al. JIKEI HEART Study-a morbi-mortality and remodeling study with valsartan in Japanese patients with hypertension and cardiovascular disease [J]. Cardiovase Drugs Ther, 2004, 18 (4) : 305-309. 被引量:1
  • 8Burges RA, Gardiner DG, Gwilt M, et al. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors [J]. J Cardiovasc Pharmacol, 1987,9 (1): 110-119. 被引量:1
  • 9Plosker GL, Robinson DM. Amlodipine/Valsartan: fixed-dose combination in hypertension[J]. Drugs, 2008,68 (3) : 373-381. 被引量:1
  • 10Flesch G, MUller P, Lloyd P. Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin Ⅱ receptor antagonist, in man[J]. Eur J Clin Pharmacol, 1997, 52 (2) : 115-120. 被引量:1

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部